Given that cardiac fibroblasts exhibit higher NLRP3 expression, multi‐targeted inhibition via Nrf2 activation may reduce the ROS‐NLRP3‐IL‐1β amplification loop that drives myocardial remodelling in HF. The gene discussed is NLRP3; the disease is hydrops fetalis.